Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00485341
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A,B | 2PSJ | 0.75 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 2F8P | 0.75 | |
CEI | N-[3-BENZYL-5-(4-HYDROXYPHENYL)PYRAZIN- 2-YL]-2-(4-HYDROXYPHENYL)ACETAMIDE | A | 1S36 | 0.75 | |
C12 | 2-(1-AMINO-2-HYDROXYPROPYL)-4-(4- HYDROXYBENZYL)-1-(2-OXOETHYL)-1H- IMIDAZOL-5-OLATE | A | 2FZU | 0.76 | |
CR8 | 2-[1-AMINO-2-(1H-IMIDAZOL-5-YL)ETHYL]- 1-(CARBOXYMETHYL)-4-[(4-OXOCYCLOHEXA- 2,5-DIEN-1-YLIDENE)METHYL]-1H-IMIDAZOL- 5-OLATE | A,B,C,D | 2VVI | 0.71 | |
CR8 | 2-[1-AMINO-2-(1H-IMIDAZOL-5-YL)ETHYL]- 1-(CARBOXYMETHYL)-4-[(4-OXOCYCLOHEXA- 2,5-DIEN-1-YLIDENE)METHYL]-1H-IMIDAZOL- 5-OLATE | A,B,C,D | 1ZUX | 0.71 | |
CR8 | 2-[1-AMINO-2-(1H-IMIDAZOL-5-YL)ETHYL]- 1-(CARBOXYMETHYL)-4-[(4-OXOCYCLOHEXA- 2,5-DIEN-1-YLIDENE)METHYL]-1H-IMIDAZOL- 5-OLATE | A,B | 2DDD | 0.71 | |
CR8 | 2-[1-AMINO-2-(1H-IMIDAZOL-5-YL)ETHYL]- 1-(CARBOXYMETHYL)-4-[(4-OXOCYCLOHEXA- 2,5-DIEN-1-YLIDENE)METHYL]-1H-IMIDAZOL- 5-OLATE | A,B | 2DDC | 0.71 | |
CR8 | 2-[1-AMINO-2-(1H-IMIDAZOL-5-YL)ETHYL]- 1-(CARBOXYMETHYL)-4-[(4-OXOCYCLOHEXA- 2,5-DIEN-1-YLIDENE)METHYL]-1H-IMIDAZOL- 5-OLATE | A,B,C,D | 2VVH | 0.71 | |
CR8 | 2-[1-AMINO-2-(1H-IMIDAZOL-5-YL)ETHYL]- 1-(CARBOXYMETHYL)-4-[(4-OXOCYCLOHEXA- 2,5-DIEN-1-YLIDENE)METHYL]-1H-IMIDAZOL- 5-OLATE | A,B | 2GW3 | 0.71 | |
1HP | 4-(2-amino-1-methyl-1H-imidazo[4,5- b]pyridin-6-yl)phenol | A,B | 2QSE | 0.71 | |
C60 | [[[3-(2-METHYL-PROPANE-2-SULFONYL)- 1-BENZENYL]-2-PROPYL]-CARBONYL- HISTIDYL]-AMINO-[CYCLOHEXYLMETHYL]- [2-HYDROXY-4-ISOPROPYL]-PENTAN- 5-OIC ACID BUTYLAMIDE | A | 1RNE | 0.73 | |
ALH | 6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE | A,B | 1UNG | 0.73 | |
APT | 2-AMINO-6-[(4-CARBOXY-PHENYLAMINO)- METHYL]-4-HYDROXY-PTERIDIN-1-IUM | A,B | 1QCJ | 0.7 | |
CK9 | 2-{[(2-{[(1R)-1-(HYDROXYMETHYL)PROPYL]AMINO}- 9-ISOPROPYL-9H-PURIN-6-YL)AMINO]METHYL}PHENOL | X | 2A0C | 0.71 | |
C1B | H | 2B7D | 0.75 | ||
121 | 2-(3-HYDROXY-PYRIDIN-2-YL)-1H-BENZOIMIDAZOLE- 5-CARBOXAMIDINE | H,I,L | 1GHY | 0.72 | |
FR2 | 1-((1R)-1-(HYDROXYMETHYL)-3-PHENYLPROPYL)- 1H-IMIDAZOLE-4-CARBOXAMIDE | A | 1NDW | 0.71 | |
4RB | 4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2- b]pyridazin-3-yl)benzoic acid | A | 3BQR | 0.72 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHJ | 0.72 | |
COP | N-(4-CARBOXY-4-{4-[(2,4-DIAMINO- PTERIDIN-6-YLMETHYL)-AMINO]-BENZOYLAMINO}- BUTYL)-PHTHALAMIC ACID | A | 1OHK | 0.72 | |
G14 | 2-phenyl-1H-imidazole-4-carboxylic acid | A,B | 3GRJ | 0.72 | |
AKP | N-(PYRAZIN-2-YLCARBONYL)LEUCYLISOLEUCYL- N~1~-{1-[2-({1-CARBOXY-2-[4-(PHOSPHONOOXY)PHENYL]ETHYL}AMINO)- 1,1-DIHYDROXY-2-OXOETHYL]BUT-3- ENYL}-3-CYCLOHEXYLALANINAMIDE | A,B | 1RGQ | 0.73 | |
GPB | N-[4-[2-(2-AMINO-4-METHYL-7H-PYRROLO[2,3- D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYL]GLUTAMIC ACID | A | 1E26 | 0.7 | |
43P | 4-(1H-IMIDAZOL-4-YL)-3-(5-ETHYL- 2,4-DIHYDROXY-PHENYL)-1H-PYRAZOLE | A | 1YC4 | 0.72 | |
228 | N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]- 1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN- 4-YL]-D-PROLINAMIDE | A | 2ORO | 0.74 | |
4F3 | [2-(1-AMINO-2-HYDROXY-PROPYL)-4- (4-FLUORO-1H-INDOL-3-YLMETHYL)- 5-HYDROXY-IMIDAZOL-1-YL]-ACETIC ACID | A | 1RM9 | 0.71 | |
CX1 | N-[(benzyloxy)carbonyl]-L-histidyl- N-methyl-L-phenylalanyl-L-tyrosine | B | 3C72 | 0.9 |